InVivo Therapeutics (NSDQ:NVIV) said yesterday it made Dr. Richard Toselli’s spot in the corner office permanent, lifting him from acting CEO to prez and CEO. Dr. Toselli will maintain his position on the company’s board and as its chief medical officer, the position he was given when he joined the company last July. Prior to joining InVivo, […]
Luxottica
EU launches full-scale probe into $54B Essilor-Luxotica merger
The European Commission plans to investigate whether the €46 billion merger of Luxottica (NYSE:LUX) and Essilor (EPA:EI) could drive competitors away from the market or hike prices, according to Reuters. The companies hold high-ranking positions in the ophthalmic lens and eyewear industries. Earlier this month, Luxottica and Essilor decided not to offer concessions in a preliminary review by antitrust […]
Essilor, Luxotica rebuff EU anti-trust regulators
(Reuters) –Luxottica (NYSE:LUX) and Essilor (EPA:EI) have not offered any concessions to allay EU antitrust regulators’ concerns over their proposed 46-billion-euro ($55.2 billion) merger, increasing the possibility of a lengthy EU investigation into the deal. Italian eyewear maker Luxottica, which owns brands such as Ray-Ban and Oakley, and French lens manufacturer Essilor had until Sept. 19 to offer […]
Eyewear giants Essilor, Luxottica to merge
Italian eyewear maker Luxottica (NYSE:LUX) and France’s leading lens manufacturer, Essilor (EPA:EI), have reached a €46 billion ($49 billion) agreement to merge and create a global eyewear company with annual revenue of more than €15 billion. “Finally … 2 products which are naturally complementary – namely frames and lenses – will be designed, manufactured and […]